Drug Profile
GS 5801
Alternative Names: GS-5801Latest Information Update: 20 Sep 2023
Price :
$50
*
At a glance
- Originator Gilead Sciences
- Class Antivirals; Small molecules
- Mechanism of Action Histone demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 20 Sep 2023 Discontinued - Phase-I for Hepatitis B in New Zealand (PO)
- 20 Sep 2023 Discontinued - Preclinical for Hepatitis B in USA (PO)
- 28 Nov 2020 No recent reports of development identified for preclinical development in Hepatitis-B in USA (PO)